Rona Ortenberg

4.1k total citations
23 papers, 700 citations indexed

About

Rona Ortenberg is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rona Ortenberg has authored 23 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rona Ortenberg's work include Radiopharmaceutical Chemistry and Applications (7 papers), Cell Adhesion Molecules Research (7 papers) and Peptidase Inhibition and Analysis (6 papers). Rona Ortenberg is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Cell Adhesion Molecules Research (7 papers) and Peptidase Inhibition and Analysis (6 papers). Rona Ortenberg collaborates with scholars based in Israel, United States and Australia. Rona Ortenberg's co-authors include Gal Markel, Michal J. Besser, Jacob Schachter, Sivan Sapoznik, Iris Barshack, Eyal Greenberg, Yael Nemlich, Menashe Bar‐Eli, Orit Itzhaki and Camila Avivi and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Rona Ortenberg

22 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rona Ortenberg Israel 15 375 254 218 149 143 23 700
Sabine Münkel Germany 10 306 0.8× 167 0.7× 321 1.5× 118 0.8× 71 0.5× 10 565
Francesca Iommelli Italy 11 239 0.6× 122 0.5× 128 0.6× 77 0.5× 138 1.0× 29 505
Elisa Melucci Italy 18 421 1.1× 465 1.8× 144 0.7× 67 0.4× 244 1.7× 31 871
James W. Purcell United States 13 271 0.7× 295 1.2× 125 0.6× 56 0.4× 80 0.6× 18 591
Casey W. Shuptrine United States 10 225 0.6× 264 1.0× 294 1.3× 179 1.2× 43 0.3× 13 588
Steven King United States 3 288 0.8× 116 0.5× 53 0.2× 81 0.5× 130 0.9× 8 469
Roberto Sommavilla Switzerland 8 210 0.6× 184 0.7× 142 0.7× 238 1.6× 46 0.3× 16 452
J. Gutheil United States 5 372 1.0× 254 1.0× 53 0.2× 133 0.9× 122 0.9× 12 630
Eszter Molnár Germany 10 191 0.5× 144 0.6× 354 1.6× 77 0.5× 44 0.3× 16 555
Maria Jure‐Kunkel United States 12 196 0.5× 575 2.3× 483 2.2× 68 0.5× 112 0.8× 36 793

Countries citing papers authored by Rona Ortenberg

Since Specialization
Citations

This map shows the geographic impact of Rona Ortenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rona Ortenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rona Ortenberg more than expected).

Fields of papers citing papers by Rona Ortenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rona Ortenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rona Ortenberg. The network helps show where Rona Ortenberg may publish in the future.

Co-authorship network of co-authors of Rona Ortenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Rona Ortenberg. A scholar is included among the top collaborators of Rona Ortenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rona Ortenberg. Rona Ortenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shapira, Guy, et al.. (2025). Circulating microRNA signatures as potential biomarkers differentiating diabetic, prediabetic, and healthy individuals. Frontiers in Endocrinology. 16. 1699100–1699100.
2.
Galore-Haskel, Gilli, Eyal Greenberg, Inbal Yahav, et al.. (2020). microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy. Cancer Immunology Immunotherapy. 70(6). 1541–1555. 6 indexed citations
3.
Baruch, Erez N., Rona Ortenberg, Camila Avivi, et al.. (2020). Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions. OncoImmunology. 9(1). 1741267–1741267. 2 indexed citations
4.
Ortenberg, Rona, Michal J. Besser, Iris Barshack, et al.. (2018). Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells. Neoplasia. 20(4). 401–409. 11 indexed citations
5.
Nemlich, Yael, Erez N. Baruch, Michal J. Besser, et al.. (2018). ADAR1-mediated regulation of melanoma invasion. Nature Communications. 9(1). 2154–2154. 38 indexed citations
6.
Vitenshtein, Alon, Yiska Weisblum, Anne Halenius, et al.. (2016). CEACAM1-Mediated Inhibition of Virus Production. Cell Reports. 15(11). 2331–2339. 18 indexed citations
7.
Ortenberg, Rona, Sivan Sapoznik, Douglas Zippel, et al.. (2015). Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy. Journal of Immunology Research. 2015. 1–8. 12 indexed citations
8.
Zippel, Douglas, et al.. (2014). A longitudinal study of CEACAM1 expression in melanoma disease progression. Oncology Reports. 33(3). 1314–1318. 11 indexed citations
9.
Ortenberg, Rona, Gilli Galore-Haskel, Sivan Sapoznik, et al.. (2014). CEACAM1 Promotes Melanoma Cell Growth through Sox-2. Neoplasia. 16(5). 451–460. 32 indexed citations
10.
Besser, Michal J., Tsipi Shoham, Orit Harari‐Steinberg, et al.. (2013). Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies. PLoS ONE. 8(3). e57922–e57922. 24 indexed citations
11.
Itzhaki, Orit, Eyal Greenberg, Bruria Shalmon, et al.. (2013). Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma. PLoS ONE. 8(2). e57160–e57160. 47 indexed citations
12.
Nemlich, Yael, Eyal Greenberg, Rona Ortenberg, et al.. (2013). MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. Journal of Clinical Investigation. 123(6). 2703–2718. 141 indexed citations
13.
Ortenberg, Rona, Liat Hershkovitz, Sivan Sapoznik, et al.. (2012). Novel Immunotherapy for Malignant Melanoma with a Monoclonal Antibody That Blocks CEACAM1 Homophilic Interactions. Molecular Cancer Therapeutics. 11(6). 1300–1310. 59 indexed citations
14.
Sapoznik, Sivan, et al.. (2012). CEACAM1 in Malignant Melanoma: A Diagnostic and Therapeutic Target. Current Topics in Medicinal Chemistry. 12(1). 3–10. 21 indexed citations
15.
Sapoznik, Sivan, Rona Ortenberg, Gilli Galore-Haskel, et al.. (2012). CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy. Cancer Immunology Immunotherapy. 61(10). 1833–1847. 39 indexed citations
16.
Sapoznik, Sivan, Rona Ortenberg, Tamar Hamburger, et al.. (2012). Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients. SHILAP Revista de lepidopterología. 2012. 1–8. 25 indexed citations
17.
Greenberg, Eyal, Liat Hershkovitz, Orit Itzhaki, et al.. (2011). Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs. PLoS ONE. 6(4). e18936–e18936. 74 indexed citations
18.
Pe’er, Jacob, et al.. (2011). Carcinoembryonic Antigen Cell Adhesion Molecule-1 (CEACAM1) in Posterior Uveal Melanoma: Correlation with Clinical and Histological Survival Markers. Investigative Ophthalmology & Visual Science. 52(13). 9368–9368. 10 indexed citations
19.
Markel, Gal, Rachel Seidman, Michal J. Besser, et al.. (2009). Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells. PLoS ONE. 4(5). e5597–e5597. 21 indexed citations
20.
Markel, Gal, Rona Ortenberg, Rachel Seidman, et al.. (2009). Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunology Immunotherapy. 59(2). 215–230. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Münkel Breakdown of academic impact, for papers by Francesca Iommelli Breakdown of academic impact, for papers by Elisa Melucci Breakdown of academic impact, for papers by James W. Purcell Breakdown of academic impact, for papers by Casey W. Shuptrine Breakdown of academic impact, for papers by Steven King Breakdown of academic impact, for papers by Roberto Sommavilla Breakdown of academic impact, for papers by J. Gutheil Breakdown of academic impact, for papers by Eszter Molnár Breakdown of academic impact, for papers by Maria Jure‐Kunkel
Rankless by CCL
2026